Thromboemboli are a significant source of morbidity and mortality in congenital heart disease, with a markedly higher prevalence than in the general population.
High thromboembolic risk warrants clinical vigilance in congenital heart disease; leaves open optimal prevention strategies.
Thromboemboli are a well-recognized source of morbidity and mortality in patients with congenital heart disease, with an overall prevalence estimated to be 10 to 100-fold higher than age-matched co...
No takes yet. Share an insight, caveat, or question.
Paul Khairy (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: